Connection

Announcement

You can now add alternative names! Click here to add other names that you've published under.

Search Results to Maurizio Zangari

This is a "connection" page, showing the details of why an item matched the keywords from your search.

Search Results

Zangari, Maurizio

One or more keywords matched the following items that are connected to Zangari, Maurizio

Item Type	Name
Academic Article	Thalidomide and deep vein thrombosis in multiple myeloma: risk factors and effect on survival.
Academic Article	DTPACE: an effective, novel combination chemotherapy with thalidomide for previously treated patients with myeloma.
Academic Article	High-dose therapy and immunomodulatory drugs in multiple myeloma.
Academic Article	Prognostic factors in allogeneic transplantation for patients with high-risk multiple myeloma after reduced intensity conditioning.
Academic Article	Prognostic impact of cytogenetic and interphase fluorescence in situ hybridization-defined chromosome 13 deletion in multiple myeloma: early results of total therapy II.
Academic Article	Continuous absence of metaphase-defined cytogenetic abnormalities, especially of chromosome 13 and hypodiploidy, ensures long-term survival in multiple myeloma treated with Total Therapy I: interpretation in the context of global gene expression.
Academic Article	Thalidomide and hematopoietic-cell transplantation for multiple myeloma.
Academic Article	High serum-free light chain levels and their rapid reduction in response to therapy define an aggressive multiple myeloma subtype with poor prognosis.
Academic Article	Eight-year median survival in multiple myeloma after total therapy 2: roles of thalidomide and consolidation chemotherapy in the context of total therapy 1.
Academic Article	Hypercoagulable states in patients with multiple myeloma can affect the thalidomide-associated venous thromboembolism.
Academic Article	Predictive value of alkaline phosphatase for response and time to progression in bortezomib-treated multiple myeloma patients.
Academic Article	Magnetic resonance imaging in multiple myeloma: diagnostic and clinical implications.
Academic Article	Effect on survival of treatment-associated venous thromboembolism in newly diagnosed multiple myeloma patients.
Academic Article	Response to bortezomib is associated to osteoblastic activation in patients with multiple myeloma.
Academic Article	Superior 12-year survival after at least 4-year continuous remission with tandem transplantations for multiple myeloma.
Academic Article	Total therapy 2 without thalidomide in comparison with total therapy 1: role of intensified induction and posttransplantation consolidation therapies.
Academic Article	Incorporating bortezomib into upfront treatment for multiple myeloma: early results of total therapy 3.
Academic Article	The Arkansas approach to therapy of patients with multiple myeloma.
Academic Article	Myeloma of the central nervous system: association with high-risk chromosomal abnormalities, plasmablastic morphology and extramedullary manifestations.
Academic Article	Complete response in myeloma extends survival without, but not with history of prior monoclonal gammopathy of undetermined significance or smouldering disease.
Academic Article	Avascular necrosis of femoral and/or humeral heads in multiple myeloma: results of a prospective study of patients treated with dexamethasone-based regimens and high-dose chemotherapy.
Academic Article	Thalidomide paradoxical effect on concomitant multiple myeloma and myelodysplasia.
Academic Article	Anticoagulation regimens for thalidomide and lenalidomide.
Academic Article	Benefit of complete response in multiple myeloma limited to high-risk subgroup identified by gene expression profiling.
Academic Article	Thrombogenic activity of doxorubicin in myeloma patients receiving thalidomide: implications for therapy.
Academic Article	Sustained complete remissions in multiple myeloma linked to bortezomib in total therapy 3: comparison with total therapy 2.
Concept	Antineoplastic Combined Chemotherapy Protocols
Academic Article	Adverse Metaphase Cytogenetics Can Be Overcome by Adding Bortezomib and Thalidomide to Fractionated Melphalan Transplants.
Academic Article	BRAF and DIS3 Mutations Associate with Adverse Outcome in a Long-term Follow-up of Patients with Multiple Myeloma.
Academic Article	Monitoring treatment response and disease progression in myeloma with circulating cell-free DNA.
Academic Article	Three years of maintenance with VRD in multiple myeloma: results of total therapy IIIB with a 15-year follow-up.

Search Criteria

Antineoplastic Combined Chemotherapy Protocols